ZP3 promotes hepatocellular carcinoma progression via the Notch signaling pathway and is associated with the tumor microenvironment and immunotherapy response.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: high ZP3 levels presented lower TIDE scores, indicating reduced immune evasion potential and a better response to immunotherapy
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] ZP3 promotes HCC progression by activating the Notch pathway and modulating the TME, highlighting its potential as both a prognostic biomarker and a therapeutic target. [SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12957-026-04245-2.
[BACKGROUND] Zona pellucida glycoprotein 3 (ZP3) is an important member of the zona pellucida glycoprotein family.
APA
Qu C, Yan X, Li Y (2026). ZP3 promotes hepatocellular carcinoma progression via the Notch signaling pathway and is associated with the tumor microenvironment and immunotherapy response.. World journal of surgical oncology, 24(1). https://doi.org/10.1186/s12957-026-04245-2
MLA
Qu C, et al.. "ZP3 promotes hepatocellular carcinoma progression via the Notch signaling pathway and is associated with the tumor microenvironment and immunotherapy response.." World journal of surgical oncology, vol. 24, no. 1, 2026.
PMID
41664163 ↗
Abstract 한글 요약
[BACKGROUND] Zona pellucida glycoprotein 3 (ZP3) is an important member of the zona pellucida glycoprotein family. However, the underlying mechanisms and immune regulation in hepatocellular carcinoma (HCC) remain unclear.
[METHODS] The protein expression level of ZP3 in HCC tissues was detected via Western blotting (WB) and immunohistochemistry (IHC). The impact of ZP3 on tumor microenvironment (TME) modulation in HCC was analyzed via the TCGA database, and its potential for immunotherapy response was assessed via the Tumor Immune Dysfunction and Exclusion (TIDE) database. Lentivirus-mediated knockdown and overexpression of ZP3 were performed in HCC cell lines, both in vitro and in vivo via various techniques, including immunofluorescence (IF), EdU, wound healing, colony formation, migration, transcriptome sequencing, flow cytometry, and xenograft assays.
[RESULTS] We confirmed that ZP3 protein levels were significantly greater in HCC tissues than in normal tissues through WB and IHC analyses. Functionally, ZP3 knockdown in Huh7 cells reduced proliferation, migration, and invasion and slowed tumor growth in xenograft models; conversely, ZP3 overexpression in LM3 cells intensified these oncogenic traits. Mechanistically, enrichment analysis of the transcriptome data suggested that ZP3 might promote HCC progression via the Notch signaling pathway. Furthermore, ZP3 knockdown decreased key components of the Notch pathway (Jagged1, Notch1, NICD1, and Hes1), whereas ZP3 overexpression activated this pathway. ZP3 expression was significantly correlated with tumor-infiltrating immune cells (such as M0 macrophages, T cells, and NK cells) and TME scores in HCC. Notably, patients with high ZP3 levels presented lower TIDE scores, indicating reduced immune evasion potential and a better response to immunotherapy.
[CONCLUSION] ZP3 promotes HCC progression by activating the Notch pathway and modulating the TME, highlighting its potential as both a prognostic biomarker and a therapeutic target.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12957-026-04245-2.
[METHODS] The protein expression level of ZP3 in HCC tissues was detected via Western blotting (WB) and immunohistochemistry (IHC). The impact of ZP3 on tumor microenvironment (TME) modulation in HCC was analyzed via the TCGA database, and its potential for immunotherapy response was assessed via the Tumor Immune Dysfunction and Exclusion (TIDE) database. Lentivirus-mediated knockdown and overexpression of ZP3 were performed in HCC cell lines, both in vitro and in vivo via various techniques, including immunofluorescence (IF), EdU, wound healing, colony formation, migration, transcriptome sequencing, flow cytometry, and xenograft assays.
[RESULTS] We confirmed that ZP3 protein levels were significantly greater in HCC tissues than in normal tissues through WB and IHC analyses. Functionally, ZP3 knockdown in Huh7 cells reduced proliferation, migration, and invasion and slowed tumor growth in xenograft models; conversely, ZP3 overexpression in LM3 cells intensified these oncogenic traits. Mechanistically, enrichment analysis of the transcriptome data suggested that ZP3 might promote HCC progression via the Notch signaling pathway. Furthermore, ZP3 knockdown decreased key components of the Notch pathway (Jagged1, Notch1, NICD1, and Hes1), whereas ZP3 overexpression activated this pathway. ZP3 expression was significantly correlated with tumor-infiltrating immune cells (such as M0 macrophages, T cells, and NK cells) and TME scores in HCC. Notably, patients with high ZP3 levels presented lower TIDE scores, indicating reduced immune evasion potential and a better response to immunotherapy.
[CONCLUSION] ZP3 promotes HCC progression by activating the Notch pathway and modulating the TME, highlighting its potential as both a prognostic biomarker and a therapeutic target.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12957-026-04245-2.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- Cohort-Aware Agents for Individualized Lung Cancer Risk Prediction Using a Retrieval-Augmented Model Selection Framework.
- Prognostic Significance and Immune Environment Analysis Using PANoptosis Molecular Clustering in Gastric Cancer.
- Construction of a novel disulfidptosis and cuproptosis-related lncRNA signature for predicting the clinical outcome and immune response in stomach adenocarcinoma.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- Heat Shock Protein 47 as a Novel Predictive and Diagnostic Biomarker for Thrombosis in Hepatocellular Carcinoma.
- Crosstalk Between -Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.
- Risks, Benefits, and Molecular Targets of Fenugreek Administration in the Treatment of Hepatocellular Carcinoma.
- Machine learning integrating MRI and clinical features predicts early recurrence of hepatocellular carcinoma after resection.